CA2410531A1 - Combination therapy for treatment of depression - Google Patents

Combination therapy for treatment of depression Download PDF

Info

Publication number
CA2410531A1
CA2410531A1 CA002410531A CA2410531A CA2410531A1 CA 2410531 A1 CA2410531 A1 CA 2410531A1 CA 002410531 A CA002410531 A CA 002410531A CA 2410531 A CA2410531 A CA 2410531A CA 2410531 A1 CA2410531 A1 CA 2410531A1
Authority
CA
Canada
Prior art keywords
phenyl
amine
methylsulfonyl
methylethyl
sulfonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002410531A
Other languages
English (en)
French (fr)
Inventor
Phil Skolnick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2410531A1 publication Critical patent/CA2410531A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002410531A 2000-05-24 2001-05-11 Combination therapy for treatment of depression Abandoned CA2410531A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20682500P 2000-05-24 2000-05-24
US60/206,825 2000-05-24
PCT/US2001/011768 WO2001089530A2 (en) 2000-05-24 2001-05-11 Combination therapy for treatment of depression comprising an antidepressant and an ampa receptor potentiator

Publications (1)

Publication Number Publication Date
CA2410531A1 true CA2410531A1 (en) 2001-11-29

Family

ID=22768136

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002410531A Abandoned CA2410531A1 (en) 2000-05-24 2001-05-11 Combination therapy for treatment of depression

Country Status (5)

Country Link
EP (1) EP1292311A2 (ja)
JP (1) JP2004509843A (ja)
AU (1) AU2001261022A1 (ja)
CA (1) CA2410531A1 (ja)
WO (1) WO2001089530A2 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040235957A1 (en) * 2001-10-12 2004-11-25 David Bleakman Use of sulfonamide derivatives as pharmaceuticals compounds
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6889274A (en) * 1973-05-17 1975-11-20 Astra Laekemedel Ab Treatment of neurological disorders
US4148896A (en) * 1978-02-22 1979-04-10 E. I. Du Pont De Nemours And Company Antidepressant combination

Also Published As

Publication number Publication date
JP2004509843A (ja) 2004-04-02
WO2001089530A2 (en) 2001-11-29
WO2001089530A3 (en) 2002-09-12
AU2001261022A1 (en) 2001-12-03
EP1292311A2 (en) 2003-03-19

Similar Documents

Publication Publication Date Title
US6174922B1 (en) Sulphonamide derivatives
JP2022547079A (ja) てんかんを治療する方法を使用しててんかんを治療する方法
US6703425B2 (en) Sulfonamide derivatives
CA2402288A1 (en) Naphtalene derivatives and their pharmaceutical use
EP1246797B1 (en) Cyclopentyl sulfonamide derivatives
CA2338745A1 (en) Heterocyclyl sulphonamide derivatives
US20030225127A1 (en) Heterocyclic sulfonamide derivatives
WO2002014275A2 (en) Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
US20030092770A1 (en) Combination therapy for treatment of depression
US6803484B2 (en) Sulfonamide derivatives
CA2410531A1 (en) Combination therapy for treatment of depression
EP0937708B1 (en) Sulphonamide derivatives
US20030225163A1 (en) Sulfonamide derivatives
US6639107B1 (en) Cyclopentyl sulfonamide derivatives
US20040198833A1 (en) Acetylenic sulfonamide derivatives
JP2004530680A (ja) ２型糖尿病治療薬製造のためのａｍｐａ受容体増強物質の使用
US20040235957A1 (en) Use of sulfonamide derivatives as pharmaceuticals compounds
WO2001089510A2 (en) Use of an ampa receptor potentiator for the treatment of obesity
EP1409452A1 (en) Sulfonamide derivatives
WO2001094306A2 (en) (bis)sulfonamide derivatives
US20040147612A1 (en) Sulfonamide derivatives
JP2010530900A (ja) 中枢神経系活性を有する置換ピロリジン化合物

Legal Events

Date Code Title Description
FZDE Dead